Isomorphic raises $2.1B to push AI-designed drugs toward clinic
DeepMind spinout Isomorphic Labs raised $2.1 billion as Demis Hassabis now points to first AI-designed drugs entering human trials by late 2026.
AlphaFold News and Analysis
3 verified stories covering AlphaFold, product updates and industry developments.
DeepMind Picks Seoul for Its First Overseas AI Campus
Google DeepMind's Seoul campus ties South Korea's K-Moonshot agenda to AlphaFold, WeatherNext and other AI for Science programs.
AlphaFold Won a Nobel Prize. What’s Next for DeepMind?
Demis Hassabis and John Jumper won the Nobel Prize in Chemistry for AlphaFold 2, which solved the 50-year protein folding problem. Now DeepMind faces a new challenge: can it produce another breakthrough of equal magnitude amid the LLM gold rush?